CEPI expands partnership with WBVR to advance Rift Valley Fever vaccine
Novel Rift Valley fever vaccine dosed in Phase I human trial
CSO shift at BunyaVax
Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle
CEO shift at BunyaVax
BunyaVax CEO on stage at Animal AgTech Innovation Summit
BunyaVax provides technology to develop a human Rift Valley Fever vaccine in a $12.5 million project
Jochem Bossenbroek speaker at Investment Trends In Animal Health
BunyaVax featured in 10 Dutch Breakthrough Technologies for 2018
Jochem Bossenbroek invited to speak at the World Agri-Tech Innovation Summit
Jeroen Kortekaas to present at the Immuno Valley Annual Conference
BunyaVax featured in Wageningen World
Prestigious SME Instrument funding for BunyaVax
BunyaVax wins innovation award in London
BunyaVax to present at Animal Health Investment Summit
BunyaVax receives 40k Take-off grant
Jochem Bossenbroek appointed as CEO
Jeroen Kortekaas and Paul Wichgers Schreur announce vision for BunyaVax
Official launch of BunyaVax B.V.